Potential pharmacokinetic role of organic cation transporters in modulating the transcorneal penetration of its substrates administered topically
- 12 July 2013
- journal article
- research article
- Published by Springer Nature in Eye
- Vol. 27 (10) , 1196-1203
Abstract
Purpose We hypothesize organic cation transporters (OCT) may have a potential role in determining the pharmacokinetics and toxicity of organic cation drugs applied topically. Hence, in the present in vivo study, we attempted to evaluate the role of OCT in modulating the transport of its substrates after topical application. Methods New Zealand albino rabbits of either sex were used. Transcorneal penetration of OCT substrates tetraethylammonium and metformin after single instillation was evaluated in the absence and presence of OCT blockers (quinidine and atropine). Aqueous humor (AH) samples were collected through paracentesis amounting to 70–100 μl under topical anesthesia at various time intervals. The samples were subjected for estimation of both substrate as well as blocker concentrations using liquid chromatography mass spectrometry. Results Topical pre-treatment (30 min before substrate) of OCT blockers significantly decreased the transcorneal penetration of OCT substrates after single topical administration. The levels of blockers reaching AH in the presence of substrates were also modulated at 60 min after its administration as compared with its control. Conclusion OCT are functionally active in the uptake of their substrates from tear to AH. Therefore, OCT in the corneal epithelium may be positioned from apical to basolateral. When administering their substrates/blockers topically, both may be competing for OCT for their uptake across the cornea, thereby decreasing the corneal penetration. Hence OCT can have a potential pharmacokinetic role in modulating the ocular bioavailability of their substrates administered topically, which are used as ocular therapeutics.Keywords
This publication has 44 references indexed in Scilit:
- Mechanisms for membrane transport of metformin in human intestinal epithelial Caco-2 cellsBiopharmaceutics & Drug Disposition, 2011
- The Influence of Topical Diclofenac Sodium on the Ocular Hypotensive Effect of Latanoprost in Glaucoma PatientsJournal of Glaucoma, 2011
- Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metforminPharmacogenetics and Genomics, 2010
- Influence of Oct1/Oct2-Deficiency on Cisplatin-Induced Changes in UrinaryN-Acetyl-β-D-GlucosaminidaseClinical Cancer Research, 2010
- Unbound Drug Concentration in Brain Homogenate and Cerebral Spinal Fluid at Steady State as a Surrogate for Unbound Concentration in Brain Interstitial FluidDrug Metabolism and Disposition, 2009
- Effect of cationic drugs on the transporting activity of human and rat OCT/Oct 1–3in vitroand implications for drug–drug interactionsXenobiotica, 2008
- Liquid chromatography tandem mass spectrometry method for simultaneous determination of antidiabetic drugs metformin and glyburide in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 2007
- Challenges and obstacles of ocular pharmacokinetics and drug deliveryAdvanced Drug Delivery Reviews, 2006
- Sensitive and specific liquid chromatographic–tandem mass spectrometric assay for atropine and its eleven metabolites in rat urineJournal of Pharmaceutical and Biomedical Analysis, 2006
- Latanoprost and brimonidine: therapeutic and physiologic assessment before and after oral nonsteroidal anti-inflammatory therapyAmerican Journal of Ophthalmology, 2002